What is next in pharmacogenomics? Translating it to clinical practice.
about
Opening the gate for genomics data into clinical research: a use case in managing patients' DNA samples from the bench to drug development.Systems biology in drug safety and metabolism: integration of microarray, real-time PCR and enzyme approaches.Regulatory perspectives on pharmacogenomics: a review of the literature on key issues faced by the United States Food and Drug Administration.
P2860
What is next in pharmacogenomics? Translating it to clinical practice.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
What is next in pharmacogenomics? Translating it to clinical practice.
@ast
What is next in pharmacogenomics? Translating it to clinical practice.
@en
type
label
What is next in pharmacogenomics? Translating it to clinical practice.
@ast
What is next in pharmacogenomics? Translating it to clinical practice.
@en
prefLabel
What is next in pharmacogenomics? Translating it to clinical practice.
@ast
What is next in pharmacogenomics? Translating it to clinical practice.
@en
P2093
P2860
P1433
P1476
What is next in pharmacogenomics? Translating it to clinical practice.
@en
P2093
Mark W Linder
Roland Valdes
Saeed A Jortani
P2860
P304
P356
10.1517/PHGS.4.4.499.22748
P577
2003-07-01T00:00:00Z